Skip to main content

Potential Impact Of COVID-19 On Walking Assist Devices Market

The global market is expected to witness growth in the coming years, owing to factors such as the increase in the number of initiatives undertaken by governments of various countries to ensure availability of walking assist devices to a huge consumer base, rise in aging population, and increasing incidences of Debilitating Neurological Diseases & Injuries.

The global walking assist devices market is expected to reach $6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.

Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) – Global Forecast to 2020


Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=98811670

Global Walking Assist Devices Market is Segmented on:

1. Product Type
2. Geography

Product Type

Based on product, the global market is classified into gaits belts and lift vests, canes, crutches, walkers, wheelchairs, and power scooters. The wheelchairs segment of the global market is the largest and also the fastest growing segment. The rise in geriatric population across the globe and increase in the number of patients suffering from mobility impairment due to spinal cord injuries and paraplegia are some factors leading to growth of the wheelchairs segment of the global market.

Geography

The report provides a detailed analysis of the market for each region and country. Four major regions covered in the report are North America (the U.S., Canada, Mexico), Europe (Germany, France, Italy, Spain, U.K.,), and Asia-Pacific (Japan, China, India, Australia, Republic of Korea) and Rest of the World (RoW). A deep-dive analysis on pricing pattern, usage pattern, end user response matrix, market share, government initiatives, product recalls, new product launches, industry trends, and technological advancements has been detailed in the report.

Request Sample Pages:
 https://www.marketsandmarkets.com/requestsampleNew.asp?id=24035174

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific (APAC)
4. Rest of the World

Geographical Growth Analysis:

North America accounted for the largest share in the global walking assist devices market in 2014. The walking assist devices market in the North American region is mostly driven by factors, such as presence of supportive government policies, sophisticated healthcare infrastructure, and increasing geriatric population base. Europe is the fastest growing region in global market in 2014 due to increase in technological advancements in the healthcare sector and development of new products that are equipped with gadgets.

Some key players mentioned in the research report are:

walking assist devices market by new product launches, recent developments, and mergers & acquisitions. The major players operating in this market are Honda Motor Co., Ltd., Permobil Inc., GF Health Products, Inc., Invacare Corporation, Besco Medical Co., LTD., Betterlifehealthcare Ltd., C.T.M. Homecare Product, Inc., Ottobock, Ossenberg GmbH, Pride Mobility Products Corp., Aetna Inc., Sunrise Medical (US) LLC, and Karma Healthcare Ltd., among others.

Comments

Popular posts from this blog

Medical Device Reprocessing Market – Statistics and Growth Dynamics To 2022

  Expected Revenue Growth: The  global medical device reprocessing market  is projected to be valued at USD 823.5 Million in 2017 and is expected to grow at a CAGR of 16.3% during the forecast period to reach to USD 1,754 Million by 2022. Base year considered for the report is 2016. What This Report Will Provide? The growth of this market is majorly driven by the increased utilization of the low priced reprocessed medical devices as compared to new devices, increased efforts towards reducing regulated medical waste (RMW), and rising number of surgical procedures associated with the growing prevalence of chronic diseases. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent. Major Growth Boosters: The medical device reprocessing includes cleaning, disinfection, inspection, sterilization, and repackaging of used medical devices for its reuse to diagnose and treat ...

Aesthetic/Cosmetic Lasers Market Worth USD 1,132.7 Million (At A CAGR Of 10.2%)

  Increasing preference for noninvasive cosmetic procedures, increasing disposable income, technological advancements, and rising medical tourism are the major drivers of the aesthetic lasers market. However, lack of reimbursement will restrain the growth of this market. What This Report Will Provide? Factors such as multiplatform lasers provide clinicians the flexibility and versatility of several standalone systems in a single package, and provide combination therapy to synergistically treat a single indication or provide treatment addressing multiple elements of any indication is contributing to the high growth of this segment in the forecast period. Expected Revenue Growth: The global  aesthetic lasers market  is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021. Major Growth Boosters: Growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and ...

Autoinjectors Market | Newest Industry Data, Future Trends and Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs. The  global autoinjectors market  is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). In terms of Therapy, the global autoinjectors market can be segmented into: Rheumatoid Arthritis Multiple Sclerosis Diabetes Anaphylaxis Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia) By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018 On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therap...